SP1 and cancer: Protein stability analysis demonstrated that FT671 significantly promoted the degradation of both SP1 and β-Catenin in A549 cancer cells, indicating this may be one of the mechanisms for decreased SP1 by USP7 inhibition (Fig. 2E).